Scopolamine produces larger antidepressant and antianxiety effects in women than in men. - Wikidata - awgldk - TriplyDB

Scopolamine produces larger antidepressant and antianxiety effects in women than in men.

Scopolamine produces larger antidepressant and antianxiety effects in women than in men.

http://www.wikidata.org/entity/Q34660507

about

Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review GABA interneurons mediate the rapid antidepressant-like effects of scopolamine.The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?Cholinergic blockade frees fear extinction from its contextual dependency Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses.Antidepressant treatment history as a predictor of response to scopolamine: clinical implications.Distinct contributions of human hippocampal theta to spatial cognition and anxiety Baseline vitamin B12 and folate levels do not predict improvement in depression after a single infusion of ketamine.Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior.Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity.Beyond serotonin: newer antidepressants in the future.Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections.Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.Elevated Hippocampal Cholinergic Neurostimulating Peptide precursor protein (HCNP-pp) mRNA in the amygdala in major depression.Measures of anxiety, amygdala volumes, and hippocampal scopolamine phMRI response in elderly female rhesus macaques.The impact of HIV/AIDS on compliance with antidepressant treatment in major depressive disorder: A prospective study in a South African private healthcare cohort Baseline mood-state measures as predictors of antidepressant response to scopolamine.Human biomarkers of rapid antidepressant effects Species-conserved reconfigurations of brain network topology induced by ketamine Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder.Pulsed intravenous administration of scopolamine produces rapid antidepressant effects and modest side effects.Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine Muscarinic receptors: their roles in disorders of the central nervous system and potential as therapeutic targets.Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder.Five potential therapeutic agents as antidepressants: a brief review and future directions.Acute ketamine challenge increases resting state prefrontal-hippocampal connectivity in both humans and rats.Possible directions for the discovery of new antidepressant treatments.Cholinergic modulation of auditory processing, sensory gating and novelty detection in human participants.Serotonin 2C receptor antagonists induce fast-onset antidepressant effects.Increased noradrenaline levels in the rostral pons can be reversed by M1 antagonist in a rat model of post-traumatic stress disorder.Establishing zebrafish as a model to study the anxiolytic effects of scopolamine.Serendipity strikes again: scopolamine as an antidepressant agent in bipolar depressed patients.Methylene blue and its analogues as antidepressant compounds.Do psychoactive drugs have a therapeutic role in compulsivity? Studies on schedule-induced polydipsia.Circuit and synaptic mechanisms of repeated stress: Perspectives from differing contexts, duration, and development.Emerging drugs for major depressive disorder: an update.Convergent Mechanisms Underlying Rapid Antidepressant Action.

P2860

Q26822244-7676FC39-BA8C-44C1-954B-AE916DA3F14B Q27329758-C9CA5311-5F95-4991-89D2-11E5A1AEBA4B Q28082434-EF7C369E-83E7-4093-81F2-D8D46DCE7E27 Q30443020-E992DC35-3ACD-4C4A-9D2A-E28D5D299160 Q30544800-FE700E16-94FC-4462-B737-AD044791AE12 Q33647744-600FDE2F-49C1-4596-A4B2-AA7C1ED9CEB2 Q34216470-1C252A5D-B0A9-4430-8240-2E6194862384 Q34241455-DFEA62BF-1A5D-4A37-AA2E-D1C9484F8503 Q34304101-581F8918-E665-4890-B50B-D03A6B528F44 Q34512818-28FEFC0D-4F02-45B0-BABC-F733922AC895 Q34557706-DF461567-F629-404F-A278-79084DF93718 Q34661281-5F601C11-0EF1-4B8E-94FF-781C94AE9882 Q34766451-0D0BC08A-5498-456E-9B23-59F4AA23F232 Q35054681-647040BC-4D0C-4898-854A-1C7B2A315EC9 Q35287782-0471CD37-CF82-4A34-ABF7-C5D510F9E22D Q35376700-D0554902-73B0-454A-BD63-5A9D68AC661F Q35424733-5107C26E-3454-4CC4-9716-C62B4C3E972D Q36296905-AD051C33-D7A2-4761-A6EC-8C78B445E8BB Q36902074-0DE759FB-B25D-4F27-9D11-A0B6406BF125 Q36915397-1011840E-60B0-4D38-9D4D-69AF73D7E790 Q37029596-B5E9339E-CC9C-4A8F-86D9-87C139519758 Q37238950-E37C52D0-1627-4800-85CE-B69D344FD92D Q37668009-EED44EF9-CE9F-4071-8F34-68285BF6008E Q37954379-8698C1E1-FA46-4DAA-8788-BB9DCC94A22B Q38543238-1072EBCF-5AF1-40C5-AAF4-8811E4EA2FF5 Q38574831-40C2D16D-B39D-4AC9-83D2-301DC29F348E Q40726876-8FC81FBE-575E-40CD-AF99-13E22D86F9C8 Q42546833-FEC19BE9-4275-4F1C-8441-BC68498EF275 Q43613870-7A207C10-ED5C-48F1-A9CC-33998BA0A0EB Q44036427-F7B07409-1F7B-447E-843C-1EDF4F1FC964 Q44461164-F4453685-22E1-4B47-89BD-63EE0104A5A7 Q44611311-9CCAE284-999A-4BB2-A287-6CE2D5D9FBD0 Q46030905-110AB02B-3217-46DD-B2ED-CFAC99C1D506 Q46327960-4E94F38C-7494-4862-9B2C-2CB585D60D7E Q47192906-CE518594-D2C5-4357-9755-B5ABC93F40B8 Q47251080-397A7030-0CEC-4FDD-957D-6415CC15F707 Q48692644-844E7A67-BDD0-4354-BC54-4AF2DF4557B1 Q52667723-4077C2F1-4643-41B8-B9E7-F81D92C5F085

P2860

Scopolamine produces larger antidepressant and antianxiety effects in women than in men.

http://www.wikidata.org/entity/Q34660507

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Scopolamine produces larger antidepressant and antianxiety effects in women than in men.

@ast

Scopolamine produces larger antidepressant and antianxiety effects in women than in men.

@en

Scopolamine produces larger antidepressant and antianxiety effects in women than in men.

@nl

type

label

Scopolamine produces larger antidepressant and antianxiety effects in women than in men.

@ast

Scopolamine produces larger antidepressant and antianxiety effects in women than in men.

@en

Scopolamine produces larger antidepressant and antianxiety effects in women than in men.

@nl

prefLabel

Scopolamine produces larger antidepressant and antianxiety effects in women than in men.

@ast

Scopolamine produces larger antidepressant and antianxiety effects in women than in men.

@en

Scopolamine produces larger antidepressant and antianxiety effects in women than in men.

@nl

P1433

Q34660507-4B2C1987-BA2A-4152-ACDC-B7F1002AE3D5

P1476

Q34660507-828E49F9-0529-4D07-A6B1-9847EC30E10B

P2093

Q34660507-4B2528A4-24CE-4A0A-B357-BD8B0EB647F4

Q34660507-61B4380F-A9C9-46D5-995D-702F5B95C6FD

Q34660507-8BB4E312-F901-4B2D-B636-1048F28145BD

P2860

Q34660507-01325D0A-DD2C-495A-89F4-012AE425A273

Q34660507-032ED7A6-F4AE-4706-9B72-F6156670669F

Q34660507-0492747A-C407-4B15-8253-7E88F0174D04

Q34660507-070C2AC2-90AA-4775-A680-E8F167783DE9

Q34660507-0854E6EC-064A-4B46-A444-495ACAC332B8

Q34660507-0A08D8C9-2818-4907-8532-A38D73468F73

Q34660507-0A515354-0C11-4EA9-9D96-F22F032BE0F1

Q34660507-1C0ACC02-C80C-4478-86DF-E21CA7E05553

Q34660507-1F38579F-2199-4BF5-A81F-0767A6199BA1

Q34660507-200F1332-8AC4-4F78-BFA8-1EEAB8AD4772

P2888

Q34660507-DEA9A5C3-E3DE-4EBD-8EEA-858157B129DB

P304

Q34660507-ECB8DDB3-D09D-4683-90BF-1571125A35E4

P31

Q34660507-A30342C6-FFF3-4A4B-90B4-8D3C077F1EC8

P356

Q34660507-47C88F85-3E0F-431E-8B6E-D2BA0987A1B1

P407

Q34660507-5E19F7E8-2AC0-4301-89D6-7818A8BF4B42

P433

Q34660507-980AF666-C9C1-45C8-8F18-73A92439AC13

P478

Q34660507-05D93B0D-B8C3-4328-BE1D-01E877063AC9

P50

Q34660507-4E7A48E7-6A96-40B4-9ACC-43A30F0AE2AD

P577

Q34660507-0D70C572-F873-4796-9328-50ED6954A59E

P5875

Q34660507-2A4D1A55-6014-4277-B3D6-15C5E30238E6

P6179

Q34660507-E549CF04-E3B2-4DB5-BAE5-45A8CD709560

P698

Q34660507-06416A6F-7390-421B-9727-80E5ED89CB48

P932

Q34660507-707A33FA-2515-424D-8B51-A4805EA7AB78

P356

P1433

Neuropsychopharmacology

P1476

Scopolamine produces larger antidepressant and antianxiety effects in women than in men.

@en

P2093

Ashish Khanna

http://www.w3.org/2001/XMLSchema#string

Elana M Hoffman

http://www.w3.org/2001/XMLSchema#string

Maura L Furey

http://www.w3.org/2001/XMLSchema#string

P2860

The assessment of anxiety states by rating

A rating scale for mania: reliability, validity and sensitivity

[Muscarinic receptors modulate the mRNA expression of NMDA receptors in brainstem and the release of glutamate in periaqueductal grey during morphine withdrawal in rats].

Acetylcholine mediates the estrogen-induced increase in NMDA receptor binding in CA1 of the hippocampus and the associated improvement in working memory.

Basal forebrain afferent projections modulating cortical acetylcholine, attention, and implications for neuropsychiatric disorders.

Gender differences in depression and antidepressant pharmacokinetics and adverse events.

Women's issues in mood disorders.

Tracking the estrogen receptor in neurons: implications for estrogen-induced synapse formation

Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression.

Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism.

P2888

P304

2479-2488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2010.131

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Wayne C. Drevets

P577

2010-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45828210

http://www.w3.org/2001/XMLSchema#string

P6179

1050607938

http://www.w3.org/2001/XMLSchema#string

P698

20736989

http://www.w3.org/2001/XMLSchema#string

P932

3055321

http://www.w3.org/2001/XMLSchema#string